Related Experiment Video
Updated: Aug 28, 2025

Cox-Maze IV Procedure Concomitant with Valvular Surgery In Situs Inversus Dextrocardia: A Single-Center Experience in China
Published on: February 11, 2022
When Heart Team Really Counts: Radical Excision of Intracardiac Leiomyomatosis
Francesco Negri1, Annamaria De Bellis2, Massimo Burelli2
1Division of Cardiology, Cardiothoracic Department, Azienda Sanitaria Universitaria Integrata di Udine, Italy.
Insights
Intravenous leiomyomatosis (IVL) is a rare tumor with high recurrence. A multidisciplinary team approach shows promise for treating intracardiac leiomyomatosis (ICL), a complex form of IVL.
Area of Science:
- Cardiovascular Medicine
- Oncology
- Surgical Oncology
Background:
- Intravenous leiomyomatosis (IVL) presents as rare, complex tumors.
- IVL exhibits high recurrence rates post-surgical removal.
- IVL can involve multiple organs, including pulmonary embolization.
Abstract:
Intravenous leiomyomatosis (IVL) are rare and complex tumors, characterized by high rates of recurrences after surgical removal and the capability of multi-organ involvement including pulmonary embolization. Regarding the surgical treatment of Intracardiac Leiomiomatosis (ICL), only few articles have been published and no controlled data are available. A combined approach that involves a Team of Cardiologists, Heart Surgeons, Vascular surgeons and Radiologists seems to be successful in treating ICL.
More Related Videos
12:45Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing
Published on: December 11, 2017
09:11Cell-based Therapy for Heart Failure in Rat: Double Thoracotomy for Myocardial Infarction and Epicardial Implantation of Cells and Biomatrix
Published on: September 22, 2014